• 12398 Citations
  • 61 h-Index
1982 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nicoletta Colombo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Platinum Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
trabectedin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Carboplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

Colombo, N., Zaccarelli, E., Baldoni, A., Frezzini, S., Scambia, G., Palluzzi, E., Tognon, G., Lissoni, A. A., Rubino, D., Ferrero, A., Farina, G., Negri, E., Pesenti Gritti, A., Galli, F., Biagioli, E., Rulli, E., Poli, D., Gerardi, C., Torri, V., Fossati, R. & 1 others, D'Incalci, M., Sep 20 2019, In : British Journal of Cancer.

Research output: Contribution to journalArticle

trabectedin
Carboplatin
Platinum
Ovarian Neoplasms
Safety

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J. W., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J. Y., Bologna, A., Carrasco-Alfonso, M. J. & 1 others, Harter, P., Jan 1 2019, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Open Access
Ovarian Neoplasms
Survival Analysis
Placebos
Maintenance
Drug Therapy

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S. & 9 others, Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L. & Russo, A., Aug 1 2019, In : Critical Reviews in Oncology/Hematology. 140, p. 67-72 6 p.

Research output: Contribution to journalReview article

Open Access
Ovarian Neoplasms
BRCA1 Gene
Neoplasms
Primary Prevention
Secondary Prevention

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

Gadducci, A., Grosso, F., Scambia, G., Raspagliesi, F., Colombo, N., Grignani, G., Casali, P., Sanfilippo, R., Buonadonna, A., Santoro, A., Bruzzone, M., Artioli, G., Lorusso, D., Biagioli, E., Fossati, R., Galli, F., Negri, E., Rulli, E., Torri, V. & D’Incalci, M., 2018, In : British Journal of Cancer. 119, 5, p. 565-571 7 p.

Research output: Contribution to journalArticle

trabectedin
Leiomyosarcoma
docetaxel
gemcitabine
Drug Therapy